Does BPC 157lower blood pressure Peptides, particularly those derived from food proteins, are emerging as a promising area of research for managing blood pressure作者：A Cataliotti·2012·被引用次数：39—Furthermore, we previously demonstrated thatB-type natriuretic peptide (BNP) supplementationhas BP-lowering actions in models of acute and chronic .... These small chains of amino acids can exert significant BP-lowering actions through various mechanisms, offering a potential novel alternative or supplement to traditional hypertension treatments. While research is ongoing, evidence suggests that specific peptides can influence the body's systems involved in blood pressure regulation, leading to notable reductions.
The impact of peptides on blood pressure is primarily attributed to their ability to interact with key physiological pathways. A well-documented mechanism involves the inhibition of the angiotensin-converting enzyme (ACE).作者：L Seppo·2003·被引用次数：881—L. helveticus LBK-16H fermented milk containing bioactive peptidesin normal daily use has a blood pressure–lowering effect in hypertensive subjects. ACE plays a crucial role in the renin-angiotensin-aldosterone system (RAAS), which regulates blood volume and vascular tone. By inhibiting ACE, certain peptides can reduce the production of angiotensin II, a potent vasoconstrictor, thereby leading to lower blood pressure. This action also prevents the inactivation of bradykinin, a substance that promotes vasodilation and further contributes to blood pressure reductionMANP (M-Atrial Natriuretic Peptide) Reduces Blood ....
Beyond ACE inhibition, other peptides demonstrate efficacy through different pathways. Natriuretic peptides, for instance, are natural hormones known for their potent blood pressure-lowering effects. They work by promoting the excretion of sodium and water by the kidneys, which in turn reduces blood volume and pressure.New blood pressure study misses the mark Research is exploring synthetic or modified versions of these peptides, such as M-atrial natriuretic peptide (MANP), for their therapeutic potential. MANP has shown promise in potentiating the effects of diuretic medications and suppressing the RAAS.
Furthermore, some peptides derived from food sources, like casein or soy, have demonstrated effectiveness in both animal studies and limited human trials. These food-protein-derived antihypertensive peptides can significantly reduce blood pressure in individuals with prehypertension and hypertension. The specific properties and effectiveness can depend on factors like molecular weight and amino acid sequence.
The landscape of peptides for blood pressure management is diverse, encompassing natural compounds and synthetically developed molecules.
* Food Protein-Derived Peptides: These are perhaps the most extensively studied category. Peptides derived from milk proteins (like casein), soy, fish (such as bonito), and even green tea have shown antihypertensive properties. For example, casein-derived peptides and peptides from black soy have been found to reduce blood pressure and oxidative stress.作者：V Cannone·2022·被引用次数：7—A first in human study ofMANP in essential hypertension has demonstrated its unique properties of aldosterone suppression and blood pressure reduction. Green tea peptides may lower blood pressure by influencing signaling pathways like Ang II/TGF-β1/SMADGLP-1-based therapies for the treatment of resistant ....
* Natriuretic Peptides: This class includes naturally occurring hormones like atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). Research into their synthetic counterparts, like MANP, is exploring their direct therapeutic application. These peptides are powerful regulators of fluid balance and vascular tone.
* GLP-1 Receptor Agonists: While primarily known for their role in diabetes management and weight loss, glucagon-like peptide-1 (GLP-1) receptor agonists, such as tirzepatide, have also demonstrated a significant ability to lower blood pressure. This effect is often linked to their potent weight-reducing properties, as weight loss is a well-established strategy for managing hypertension. Studies have shown tirzepatide to significantly reduce both systolic and 24-hour ambulatory blood pressure in individuals with obesity.Effects of black soy peptide supplementation on blood ...
* Other Emerging Peptides: Research is also investigating peptides derived from sources like high voltage-gated calcium channels, which have demonstrated potent blood pressure-reducing effects in preliminary studies.
The use of peptides for blood pressure management offers several potential advantages. They can act through multiple pathways, potentially providing broader efficacy than single-target drugs.作者：AN Makaryus·2025—GLP-1 RAs are potent weight-reducing agents, and weight loss is a well-known strategy to lower blood pressure in overweight individuals. For individuals seeking natural or complementary approaches, food-protein-derived peptides offer an attractive option. Furthermore, the discovery of peptides like GLP-1 receptor agonists highlights how advancements in one therapeutic area can yield benefits in others, such as hypertension management.Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure ...
However, it is crucial to approach peptide therapy with informed caution. While some peptides, like those derived from fermented milk or specific food sources, have shown positive results, the evidence for others might still be limited, particularly in large-scale human trials. For instance, while casein-derived peptides show promise, human trial evidence remains less extensive than animal studies.
The use of certain peptides, especially synthetic ones or those with potent physiological effects, necessitates medical supervision. Side effects, though often minimal with food-derived peptides, can occur and vary depending on the specific peptide and individual response. For example, while some ACE inhibitory peptides have been shown to lower blood pressure with no adverse effects, other peptide therapies might carry different risk profiles.
Moreover, the concept of peptide therapy is broad, and not all peptides are designed or proven to lower blood pressure. Some peptides might even contribute to hypertension.The antihypertensive effect of peptides: A novel alternative ... For instance, research is exploring how certain peptide antigens can activate T cells and contribute to hypertension. Therefore, it is vital to distinguish between peptides with established antihypertensive properties and those with different or unknown effects on blood pressure.
The research into peptides to lower blood pressure is a dynamic and evolving field. Continued investigation into novel peptide sources, mechanisms of action, and clinical efficacy is expected to expand the therapeutic armamentarium for hypertension. The integration of peptide therapy into comprehensive lifestyle management, as suggested by some research indicating peptide therapy can be a useful addition to a healthy lifestyle, holds significant promise.
While peptides like those from food proteins and natriuretic peptides show clear potential, and GLP-1 receptor agonists offer a dual benefit for weight and blood pressure, further research is essential to fully understand their long-term safety, optimal dosing, and specific applications. As scientific understanding grows, peptides may indeed become a more prominent tool in the ongoing effort to manage and reduce the global burden of high blood pressure.New weight loss medication may help lower blood ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.